A Decline in Cognitive Function Should Lead to a Change in Disease-Modifying Therapy – Commentary

Multiple Sclerosis - United States
doi 10.1177/1352458518787721
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

A Decline in Cognitive Function Should Lead to a Change in Disease-Modifying Therapy – No

Multiple Sclerosis
Neurology
2018English

A Decline in Cognitive Function Should Lead to a Change in Disease-Modifying Therapy – Yes

Multiple Sclerosis
Neurology
2018English

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in Physiology and Pathology

Frontiers in Neuroanatomy
AnatomyNeuroscienceCellularMolecular Neuroscience
2016English

Prm115 - Modeling Decline in Cognition to Decline in Function in Alzheimer’s Disease (Ad)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Should Disease-Modifying Therapy Be Stopped in Patients With Rheumatoid Arthritis Before Endoprosthetic Joint Replacement?

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2011English

Health Status Decline in Α-1 Antitrypsin Deficiency: A Feasible Outcome for Disease Modifying Therapies?

Respiratory Research
PulmonaryRespiratory Medicine
2018English

Association Between Visual Impairment and Decline in Cognitive Function in a Multiethnic Asian Population

JAMA network open
Medicine
2020English

Quantitative EEG and Cognitive Decline in Parkinson’s Disease

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2016English

Predicting the Rate of Cognitive Decline in Alzheimer Disease

Alzheimer Disease and Associated Disorders
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy